conferenceseries.com
Tentative Program
Materials Chemistry 2017
conferenceseries.com 3rd International Conference on
Flu and Emerging Infectious Diseases November 07-08, 2018 | Alabama, USA
Theme: “Fighting Flu & Infections with Innovative Techniques”
**For Available Speaker Slots**
[email protected] /
[email protected]
19+ Interactive 15+ Keynote Sessions Lectures
75+
Plenary Lectures
5+ Workshops
Conference Series LLC Ltd 47 Churchfield Road, London, UK, W3 6AY Toll Free: +1-800-014-8923 Email:
[email protected] /
[email protected]
Program at a Glance
3rd International Conference on Progrram at a G Glance
Flu and Emerging Infectious Diseases November 07-08, 2018 | Alabama, USA
Day 1
Tim me
Genera al Session
09.00‐‐09.15
Inaugural Address
09.15‐‐09.45
Keynote/Plenary Talk k 1
09.45‐‐10.15
Keyynote Sessio on
Keynote/Plenary Talk k 2
10.15‐‐10.45
Keynote/Plenary Talk k 3 Panel Disccussions/Grroup Photo
Evening Sessions
Coffee e/Tea Break k 10.45‐11.00 (Networking) 11.00‐1 12.40
Emerrging Infectious Diseasees
Lunch B Break 12.40‐13.30 Facctors in the E Emergence of Infectiouus Diseases
13.30‐1 15.30
Coffee e/Tea Break k 15.30‐15.45 (Networking) 15.45‐1 17.25 T Treatment of Emerging g Infectious Diseases
Day 2
Evening Sessions
Morning Sessions
Tim me
20 Speakers for Day 1
08 8.00‐09.00
FFlu/Influenza virus
Sym mptoms and d Trreatment of Flu/Innfluenza Virrus
10.55‐12.35
Flu/Inflluenza Vacciines : Curren nt an nd Novel Ap pproach
Ant ntivirals and Theraapeutics of F Flu Disease
13.25‐15.05
Geogrraphic Distriibution and Tran nsmission off Emerging IInfectious Disease
Puublic Health Measuures to Prevent Emergging Infectio ous Diseases
09.00‐10.40
Coffee/Tea Breaak 10.40‐10 0.55 (Netwo orking)
Lunch Break 12.3 35‐13.25
Coffee/Tea Breaak 15.05‐15 5.20 (Netwo orking) P oster Sessions
30 Speakers on Day 2
Morning Sessions
Reg gistration
Awards & Closing Ceremony NOTE: Program Schedule is subject to change with final allotment of the speaker slots For more Details PS: http://flu.conferenceseries.com/
http://flu.conferenceseries.com/
[email protected] [email protected]
About Alabama
Alabama is a state in the south eastern region of the United States. It is bordered by Tennessee to the north, Georgia to the east, Florida and the Gulf of Mexico to the south, and Mississippi to the west. Alabama is the 30th largest by area and the 24th-most populous of the U.S. states. With a total of 1,500 miles (2,400 km) of inland waterways, Alabama has among the most of any state. An estimated 20 million tourists visit the state each year. Over 100,000 of these are from other countries, including from Canada, the United Kingdom, Germany and Japan. The major cities surrounding the place are Birmingham, Huntsville, Montgomery and Mobile. In the history of Alabama, no city has played a major role than that of Montgomery. Battles Wharf, Botanical gardens, Cheaha State park, Chewacla Falls, Downtown mobile, Florence, Fort Payne Depot Museum, Gulf Shores, Lake Martin, The Old Mill on Shades Creek, Neversink Pit Sinkhole and many more interesting places have made the place a best tourist spot. America’s Finest City also showcases many popular attractions for the whole family to enjoy. Some of these include Battles Wharf, Cheaha State park, Chewacla Falls, Downtown mobile, Fort Payne Depot Museum, Florence, Gulf Shores, Lake Martin, Neversink Pit Sinkhole, The Old Mill on Shades Creek. We look forward to meet you in Alabama !
Venue Updating soon...
For detailed sessions & sub-sessions, kindly visit: https://flu.conferenceseries.com/call-for-abstracts.php Submit your Abstract Online: https://flu.conferenceseries.com/abstract-submission.php Register Online: https://flu.conferenceseries.com/registration.php
Flu and Infectious Diseases 2018
Conference Highlights •
Emerging Infectious Diseases
•
Pathology of Flu/ Influenza virus
•
Geographic Distribution And Transmission of Emerging infectious disease
•
Symptoms And Treatment Of Flu/ Influenza Virus
•
Factors in the Emergence of Infectious Diseases
•
Flu/ Influenza vaccines : Current And Novel Approach
•
Host Defenses Against Emerging Infectious Diseases
•
Flu/ Influenza Vaccines And Vaccination
•
Antivirals and Therapeutics for Flu disease
•
Public Health Measures to Prevent Emerging Infectious Diseases
•
Epidemology and Public Health of Flu/ Influenza
•
Treatment of Emerging Infectious Diseases
•
Flu Vaccines And Case Reports Of Flu
•
Flu /Influenza Virus
•
•
Antigenic Variation of Flu/ Influenza Virus
Flu Virus -Advancements in Detection & Differentiation
For more about the Tracks click here to the following link https://flu.conferenceseries.com/call-for-abstracts.php
Important Links: http://rarediseases.conferenceseries.com/ e-mail us:
[email protected] [email protected]
Flu and Infectious Diseases 2018 Page 4
256th OMICS International Conference
Scientific Program
International Conference on Flu
June 08-10, 2015 Chicago, USA
Media Partners
Conference Series LLC Ltd 47 Churchfield Road, London, UK, W3 6AY Toll Free: +1-800-014-8923 Email:
[email protected];
[email protected]
Day 1
June 8, 2015
08:00-09:00 Registrations Vienna
09:00-09:30 09:30-09:35 09:35-10:05 10:05-10:35
Opening Ceremony
Keynote Forum
Introduction Scott Umlauf VaxInnate Corporation, USA Vadim Bichko ChemDiv, Inc, USA
Networking & Refreshments Break 10:35-10:55 @ Foyer 10:55-11:25
Joshua DiNapoli Sanofi Pasteur Biologics LLC, USA Group Photo
Track 1: Flu Vaccine & Vaccination Track 4: Molecular Biology of Influenza Viruses Track 9: Influenza and Antivirals Track 10: Therapeutic Approaches and Targets for Viral Infection Session Chair: Pamuk Bilsel, FluGen, Inc, USA Session Co-Chair: Masayuki Noguchi, Hokkaido University, Japan
11:25-11:45 11:45-12:05 12:05-12:25 12:25-12:45 12:45-13:05
13:45-14:05 14:05-14:25 14:25-14:45 14:45-15:05
15:25-15:45 15:45-16:05
Session Introduction Title: A novel approach for inhibiting progression of flu virus infection at early stages of the disease by inhalation of alpla-Gal/SA liposomes Uri Galili, UMass Medical School, USA Title: M2SR, a single replication universal flu vaccine Pamuk Bilsel, FluGen, Inc, USA Title: Acute allergic inflammation protects against influenza A virus induced morbidity in mice Amali E Samarasinghe, University of Tennessee Health Science Center, USA Title: Identification of critical residues in the hemagglutinin (HA) that impact the replication, stability and immunogenicity of live attenuated influenza vaccines Zhongying Chen, MedImmune / AstraZeneca, USA Title: Influenza virus-like particle vaccines elicit protective immunity in the early stage of vaccination Fu Shi Quan, Kyung Hee University School of Medicine, Korea Lunch Break 13:05-13:45 @ Athens Title: Host factors for influenza virus replication Michael M C Lai, China Medical University, Taiwan Title: Systems biology studies to dissect the regulatory mechanisms of antiviral immunity Vladimir Litvak, University of Massachusetts Medical School, USA Title: Subversion of autophagy by viral LC3 interacting regions Rupert Beale, University of Cambridge, UK Title: A simple and rapid assay for determination of susceptibility of influenza virus to neuraminidase inhibitors X James Li, Cellex Incorporated, USA Networking & Refreshments Break 15:05-15:25 @ Foyer Title: Activation of protective innate-adaptive immunity duo for conferring rapid-sustained-broad protection of vaccines against influenza De-chu Christopher Tang, VaxDome LLC, USA Title: In vivo Veritas: Influenza vaccination triggers the rapid differentiation of monocytes into dendritic cells in vivo in humans Yun-Chi Chen, Morgan State University, USA
Title: Changes in the prevalence of influenza-like illness and influenza vaccine uptake among hajj 16:05-16:25 pilgrims: A 10-year retrospective analysis of data Osamah Barasheed, University of Sydney, Australia Title: Characterization and immunogenicity in mice of rececombinant influenza haemagglutinins 16:25-16:45 produced in Leishmania tarentolae Isabelle Legastelois, Sanofi Pasteur, France Panel Discussion Day 2
June 9, 2015 Vienna
Keynote Forum 09:30-10:00
Rangaraj Selvarangan Children’s Mercy Hospital, USA
10:00-10:30
Ming Zhang University of Georgia, USA Networking & Refreshments Break 10:30-10:50 @ Athens
Track 2: Current Focus in Flu Research Track 6: Threat of Cross-Species Strains Track 7: Influenza Strains: Detection and Differentiation Track 8: Influenza Co-infection Session Chair: Rob Lambkin-Williams, hVIVO, UK Session Co-Chair: Benicio Gutiérrez-Doña, Universidad Estatal a Distancia, Costa Rica
10:50-11:10
11:10-11:30 11:30-11:50 11:50-12:10 12:10-12:30
13:10-13:30
13:30-15:00
15:20-15:50 15:50-16:20
Session Introduction Title: Structural equation modeling of male/female handwashing behaviors during the a (H1N1) pandemic influenza in 2009-2010 Benicio Gutiérrez-Doña, Universidad Estatal a Distancia, Costa Rica Title: Neutralizing antibodies directed against the influenza hemagglutinin head domain are more potent in vivo than those directed against the broadly conserved stem domain Joshua DiNapoli, Sanofi Pasteur Biologics LLC, USA Title: USDA swine influenza surveillance program Alicia Janas-Martindale, United States Department of Agriculture, USA Title: Manifestations of influenza in Romania Angelica Constanta Visan, Carol Davila University of Medicine and Pharmacy, Romania Title: Accelerating influenza research; Vaccines, antivirals, immunodulators and monoclonal antibodies. The manufacture of a new H3N2 virus for the human viral challenge model Rob Lambkin-Williams, hVIVO, UK Lunch Break 12:30-13:10 @ Athens Title: Survey of causative agents for acute respiratory infections among patients in Khartoum- State, Sudan, 2010-2011 Khalid A Enan, Central Laboratory, Sudan Workshop Title: Designing effective flu vaccines against a broad-spectrum of influenza viruses Pamuk Bilsel, FluGen, Inc, USA Networking & Refreshments Break 15:00-15:20 @ Athens Symposium on Novel Jet Injection Technology for Influenza Vaccination Title: Next generation needle-free injection systems Chris Cappello, PharmaJet Inc, USA Title: Post-marketing survey of satisfaction with needle-free administration of Afluria® seasonal influenza vaccine in a grocery pharmacy setting using novel jet injection Charles A Altman, bioCSL, USA
Title: The principal migration routes of Eurasion birds - With a focus on Israel and Central Europe Martin Kraft, Philipps University of Marburg, Germany 15:00-16:00 Poster Presentations @ Athens Panel Discussion 16:20-16:40
Day 3
June 10, 2015 Vienna
Track 3: Potential Drug Targets Track 5: Mutation and Influenza Virus Track 11: Influenza: Alternate Treatment Methods Session Chair: Masayuki Noguchi, Hokkaido University, Japan Title: Modulation of the status of influenza infection by Akt peptide inhibitor Akt-in 10:00-10:20 Masayuki Noguchi, Hokkaido University, Japan Title: The role of mHealth in the fight against flu 10:20-10:40 Bipin Thomas, Global Virus Network, USA Networking & Refreshments Break 10:40-11:00 @ Foyer Title: The Traditional treatment of flu in West Africa (Guinea-Conakry) 11:00-11:20 Sylvain Haba, Centre Des Soins Medico-Tradi-Spirituels Talithakoumi, Guinea Conakry Title: Architecture and assembly of type A influenza virus RNA polymerase 11:20-11:40 Yingfang Liu, Chinese Academy of Sciences, China Title: Use of BanLec H84T, a molecular-engineered carbohydrate binding protein, as a therapeutic for 11:40-12:00 influenza virus infections E Bart Tarbet, Utah State University, USA Lunch Break 12:00-12:40 @ Athens Award Ceremony
Bookmark your dates
2 International Conference on Flu nd
November 14-16, 2016 San Francisco, USA
Website: flu.conferenceseries.com/
conferenceseries.com
2nd International Conference on Flu
October 31- November 02, 2016 San Francisco, USA
Scientific Program
Day 1 October 31, 2016 08:00-09:00 Registrations
conferenceseries.com
Sequoia
09:00-09:30
Opening Ceremony
Keynote Forum 09:30-09:35 09:35-10:10 10:10-10:45 10:45-11:20
Introduction Title: WHO technology transfer activities for influenza vaccines Donald P Francis, Global Solutions for Infectious Diseases, USA Title: Drug development from bacterial pathogens to fight infections and cancer Ananda M Chakrabarty, University of Illinois College of Medicine, USA Title: Universal therapeutic vaccine against influenza Marek Malecki, Phoenix Biomolecular Engineering Foundation, USA Networking and Refreshment Break : 11:20-11:35 @ Foyer
11:35-12:10
Title: The human viral challenge model: Accelerating drug and vaccine development Anthony S Gilbert, hVIVO, UK
12:10-12:45
Title: Metadichol® a novel ICAM-1 inhibitor Palayakotai Raghavan, Nanorx Inc, USA
12:45-13:20
Title: FDA approved recombinant influenza vaccine Flublok protects against drift influenza viruses Manon M J Cox, Protein Sciences, USA Group Photo Lunch Break : 13:20-14:05 @ Tiburon
Sessions: Flu Vaccines: Current and Novel Approach| Flu Vaccines and Vaccination: Opportunities and Challenges for All Age Groups | Flu: Immunology & Genetics Session Chair: Donald P Francis, Global Solutions for Infectious Diseases, USA Session Introduction 14:05-14:30 14:30-14:55 14:55-15:20 15:20-15:45
15:45-16:15
Title: Diverse hosts contributing to the diversity of influenza A virus Tracey Goldstein, One Health Institute, University of California, USA Title: IL-15-dependent generation of lung tissue-resident memory CD4 T cells K Kai Mckinstry, University of Central Florida, USA Title: Memory CD4 T cell regulation of innate lymphoid cells during protective responses against influenza A virus Tara M Strutt, University of Central Florida, USA Title: Targeting the influenza A virus M2 proton channel to combat drug resistance Jun Wang, University of Arizona, USA Special Session Title : Regulation of acute inflammation by memory CD4 T cells during IAV infection Tara M Strutt, University of Central Florida, USA Networking and Refreshment Break 16:15-16:30 @ Foyer Panel Discussion
Page 10
Day 2 November 01, 2016
Sequoia
Keynote Forum 09:30-10:05
Title: Calcium folate for flu prevention and control Phillip Bertrand Berkey Moheno, SanRx Pharmaceuticals Inc., USA
10:05-10:40
Title: Innate defense mechanisms, cell death and survival, signalling and proliferation: The search for new anti-viral targets for influenza A virus Sunil K Lal, Monash University, Malaysia Networking and Refreshment Break 10:40-10:55 @ Foyer
Sessions: Pathology of Influenza Virus Infections | Flu Symptoms & Treatment | Flu Clinical Studies & Case Reports | Antivirals and Therapeutics Session Chair: Donald P Francis, Global Solutions for Infectious Diseases, USA Session Co-Chair: Palayakotai Raghavan, Nanorx Inc, USA Session Introduction Title: Dramatic changes in the development and supply of vaccines for the world 10:55-11:20 Donald P Francis, Global Solutions for Infectious Diseases, USA Title: Hemagglutinin receptor-binding specificity of H10N7 avian influenza 11:20-11:45 Tony Velkov, Monash University, Australia Title: Another look at what role in 2005-2007 global spread of H5N1 played an upregulation 11:45-12:10 by host cell dioxin of gene encoding type a influenza virus NS1 binding protein Ilya B Tsyrlov, XENOTOX Inc, USA Young Researcher Forum Title: Targeting the influenza RNA-dependent RNA polymerase 12:10-12:35 Diane Beylkin, SRI International, USA Title: Identification and characterization of influenza variants resistant to a viral 12:35-13:00 endonuclease inhibitor Gyanendra Kumar, St. Jude Children’s Research Hospital, USA Lunch Break : 13:00-13:45 @ Tiburon Title : Pregnancy and severity of infection with pandemic influenza A(H1N1)pdm09virus 13:45-14:10 Natalia Periolo, INEI-ANLIS "Carlos G. Malbran", Argentina Title : Can altering humidity reduce transmission of respiratory viruses: A pilot study in preschool 14:10-14:35 classrooms Jennifer M Reiman, Mayo Clinic, USA Title : Avian influenza A H7N9 virus efficiently infects and induces apoptosis in human CD14+ 14:35-15:00 monocytes Andrew Chak Yiu Lee, The University of Hong Kong, Hong Kong Title : Impaired mouse beta-defensin 4 response to A(H1N1)09 influenza virus challenge results in 15:00-15:25 severe infection in respiratory tract of senescent mice Zhu Houshun, The University of Hong Kong, Hong Kong Networking and Refreshment Break 15:25-15:40 @ Foyer Poster Presentations 15:40-16:40 Title: Impact on the need for hospital care, intensive care and mortality of a mass vaccination FLU-01 campaign against 2009 A(H1N1) pandemic influenza in Uppsala county Sweden Staffan P E Sylvan, Uppsala University Hospital, Sweden Title: TLR7 agonist imiquimod enhances the efficacy of 2009 pandemic H1N1 vaccine in BALB/c mice FLU-02 Li Can, The University of Hong Kong, Hong Kong Title: Assessing the performance of rapid influenza diagnostics tests in the community FLU-03 Candice Keane, University College London, UK Page 11
FLU-04 FLU-05
Title: Assessment of changes in sex hormones, cortisol and white blood cells during menstrual cycle in female asthmatic students at NAU, Nnewi, Nigeria Nkiruka Rose Ukibe, Nnamdi Azikiwe University, Nigeria Title: Jiawei-Yupingfeng-Tang, a Chinese herbal formula, inhibits respiratory virus infection in vitro and in vivo Zhanqiu Yang, Wuhan University, China Day 3 November 02, 2016
Sequoia Sessions: Surveillance Issues and Burden of Disease Session Chair: Phillip B Berkey Moheno, SanRx / CSU USA Title: Impact of umifenovir use on the reduction secondary bacterial pneumonia following 10:00-10:25 influenza Irina Leneva, I.Mechnikov Institute for Vaccines and Sera, Russia Networking and Refreshment Break 10:25-10:45 @ Foyer Title: Antiviral activity and possible mechanisms of action of Acacia nilotica against influenza A virus 10:45-11:10 Mona Timan Idriss Gassab, Sudan International University, Sudan Panel Discussion Award & Closing Ceremony Lunch Break 12:30-1:30 @ Tiburon
Bookmark your dates
3rd International Conference on
Flu & Emerging Infectious Diseases
October 30-November 01, 2017 Las Vegas, USA
e-mail:
[email protected],
[email protected] Website: http://flu.conferenceseries.com/
Page 12
